300653 正海生物
按盤價 
18.750 -0.900 (-4.580%)
18.750 -0.900 (-4.580%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.645 | 9.269 | 14.660 | 21.063 | 22.472 |
| 總資產報酬率 ROA (%) | 1.484 | 8.389 | 13.239 | 18.715 | 19.358 |
| 投入資產回報率 ROIC (%) | 1.613 | 9.064 | 14.179 | 20.226 | 21.433 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.648 | 85.877 | 87.643 | 89.901 | 88.723 |
| 營業利潤率 (%) | 21.210 | 24.504 | 41.987 | 52.839 | 48.952 |
| 息稅前利潤/營業總收入 (%) | 21.172 | 24.105 | 41.809 | 52.655 | 48.753 |
| 淨利潤/營業總收入 (%) | 18.203 | 22.632 | 37.068 | 46.164 | 42.804 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.057 | 83.286 | 83.694 | 87.543 | 93.008 |
| 價值變動淨收益/利潤總額(%) | 17.761 | 15.369 | 11.847 | 11.569 | 3.393 |
| 營業外收支淨額/利潤總額(%) | 0.087 | -1.250 | -0.085 | -0.080 | 0.017 | 償債能力分析 |
| 流動比率 (X) | 8.420 | 8.604 | 8.822 | 8.562 | 6.723 |
| 速動比率 (X) | 8.065 | 8.257 | 8.386 | 8.154 | 6.337 |
| 資產負債率 (%) | 9.838 | 9.663 | 9.318 | 10.036 | 12.341 |
| 帶息債務/全部投入資本 (%) | 1.066 | 0.603 | 1.557 | 2.205 | 2.366 |
| 股東權益/帶息債務 (%) | 9,179.319 | 16,292.830 | 6,249.212 | 4,362.996 | 4,050.358 |
| 股東權益/負債合計 (%) | 916.499 | 934.921 | 973.162 | 896.437 | 710.287 |
| 利息保障倍數 (X) | -374.719 | -250.962 | -294.261 | -369.890 | -235.612 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 64.500 | 52.235 | 49.363 | 42.093 | 37.683 |
| 存貨周轉天數 (天) | 195.502 | 226.576 | 288.338 | 333.560 | 275.121 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
